Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial
PaperCitations, authors & open-access status
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 472 citations, 2021 year and hybrid oa status.
472
Citations
2021
Year
hybrid
OA Status